P2X7 Receptors in Oligodendrocytes: A Novel Target for Neuroprotection

被引：56
|
作者：
Matute, Carlos [1 ,2 ]
机构：
[1] Univ Basque Country, CIBERNED, Dept Neurociencias, Leioa 48940, Spain
[2] Neurotek UPV EHU, Zamudio 48170, Spain
来源：
MOLECULAR NEUROBIOLOGY | 2008年 / 38卷 / 02期
关键词：
Oligodendroglia; Myelin; ATP; P2X7; Ischemia; Multiple sclerosis;
D O I：
10.1007/s12035-008-8028-x
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Intense ATP signaling through P2X7 purinergic receptors can lead to excitotoxicity, a feature which initiates neuronal demise in experimental paradigms relevant to ischemia and to traumatic injury. In addition, recent data provide evidence that oligodendrocytes also express P2X7 receptors that are activated under experimental pathological conditions involving white matter demise. Thus, this receptor subtype is a promising target for the development of new drugs to prevent white matter damage in acute and chronic diseases.
引用
收藏
页码：123 / 128
页数：6
相关论文
共 50 条
  • [21] P2X7 receptors and glioma cells
    Leticia Scussel Bergamin
    Purinergic Signalling, 2020, 16 : 253 - 254
  • [22] P2X7 receptors and glioma cells
    Bergamin, Leticia Scussel
    PURINERGIC SIGNALLING, 2020, 16 (03) : 253 - 254
  • [23] P2X7 Receptor as a Therapeutic Target
    De Marchi, Elena
    Orioli, Elisa
    Dal Ben, Diego
    Adinolfi, Elena
    ION CHANNELS AS THERAPEUTIC TARGETS, PT B, 2016, 104 : 39 - 79
  • [24] The P2X7 receptor as a therapeutic target
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Cruz-Lopez, Olga
    Lopez-Cara, Carlota
    Preti, Delia
    Borea, Pier Andrea
    Gessi, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (05) : 647 - 661
  • [25] P2X4 or P2X7: which of these two receptors is the best target to promote salivation?
    Pochet, Stephanie
    Seil, Michele
    El Ouaaliti, Malika
    Dehaye, Jean-Paul
    M S-MEDECINE SCIENCES, 2013, 29 (05): : 509 - 514
  • [26] Expression of P2X7 purinoceptors on human lymphocytes and monocytes:: evidence for nonfunctional P2X7 receptors
    Gu, BJ
    Zhang, WY
    Bendall, LJ
    Chessell, IP
    Buell, GN
    Wiley, JS
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (04): : C1189 - C1197
  • [27] The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
    Burnstock, Geoffrey
    Knight, Gillian E.
    PURINERGIC SIGNALLING, 2018, 14 (01) : 1 - 18
  • [28] The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
    Geoffrey Burnstock
    Gillian E. Knight
    Purinergic Signalling, 2018, 14 : 1 - 18
  • [29] Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model
    Johns, Alexandra E.
    Taga, Arens
    Charalampopoulou, Andriana
    Gross, Sarah K.
    Rust, Khalil
    McCray, Brett A.
    Sullivan, Jeremy M.
    Maragakis, Nicholas J.
    STEM CELLS TRANSLATIONAL MEDICINE, 2024, 13 (12) : 1198 - 1212
  • [30] P2X7 Receptors: Channels, Pores and More
    Volonte, C.
    Apolloni, S.
    Skaper, S. D.
    Burnstock, G.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (06) : 705 - 721
12345